AUPH EBITDA Margin
Aurinia Pharmaceuticals Inc · EBITDA Margin
AUPH EBITDA Margin
Latest reported60.42%period ending
AUPH EBITDA Margin (-250.00% → 60.42%)
Annual ebitda margin
High-resolution chart · PNG
AUPH ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 45.135% | |
| 13.4936% | |
| -35.9216% | |
| -77.3304% | |
| -389.0911% | |
| -205.3534% | |
| -28,230.1887% | |
| -11,647.3002% | |
| -10,859.0476% | |
| -12,332.3699% | |
| -9,371.0638% | |
| -5,646.0432% | |
| -617.4616% | |
| -145.1178% | |
| -182.5258% | |
| -124.6895% | |
| -128.3601% | |
| -366.7232% | |
| -1,461.462% | |
| -641.6221% | |
| -2,390.1331% | |
| -1,635.7285% | |
| -128.2939% | |
| -7.2331% | |
| -135.8947% | |
| -701.0829% | |
| -80% | |
| -250% |